Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,805,917
+$1,404,223 QoQ
Shares Held
121,108
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#198
of 1,348 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SFMG, LLC holds $17,137,338 across 10 Drug Manufacturers - General names. NVO ranks #1 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
121,108 | $5,805,917 | |
| 2 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 3 | JNJ |
Johnson & Johnson
|
14,871 | $3,776,787 | |
| 4 | ABBV |
AbbVie Inc.
|
5,732 | $1,442,400 | |
| 5 | AMGN |
Amgen Inc
|
1,884 | $682,234 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,704 | $347,464 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,723 | $272,139 | |
| 8 | AZN |
Astrazeneca PLC
|
1,394 | $264,330 |
All Filings in NVO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,805,917 | 121,108 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,401,694 | 119,774 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,902,944 | 116,017 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,123,876 | 110,360 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,137,703 | 103,415 | Shares | Sole | 2025-08-12 | |
| 2024-09-30 | $216,112 | 1,815 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $225,243 | 1,578 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $214,556 | 1,671 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||